Weight-loss drugs: 10 Breakthrough Technologies 2024
These drugs aren’t perfect—common side effects include nausea, diarrhea, and vomiting. Many patients must stay on the drugs for life to keep the weight off, and the long-term impacts of these treatments remain unknown. The drugs are also expensive, costing more than $1,000 per month, and most insurance plans don’t cover them for weight loss.
Nevertheless, the treatments could improve the health of millions of people. Some studies even suggest that they alleviate symptoms of heart failure. Dozens of companies are now developing new versions of these weight-loss medications, some of which can be taken orally.
In November, the US Food and Drug Administration approved Eli Lilly’s diabetes drug Zepbound for obesity. With about 70 new obesity treatments in development, six are now awaiting regulatory review.
In the coming year, expect to see more companies entering the final stages of trials and seeking approval as demand skyrockets.
These drugs aren’t perfect—common side effects include nausea, diarrhea, and vomiting. Many patients must stay on the drugs for life to keep the weight off, and the long-term impacts of these treatments remain unknown. The drugs are also expensive, costing more than $1,000 per month, and most insurance plans don’t cover them for weight loss.
Nevertheless, the treatments could improve the health of millions of people. Some studies even suggest that they alleviate symptoms of heart failure. Dozens of companies are now developing new versions of these weight-loss medications, some of which can be taken orally.
In November, the US Food and Drug Administration approved Eli Lilly’s diabetes drug Zepbound for obesity. With about 70 new obesity treatments in development, six are now awaiting regulatory review.
In the coming year, expect to see more companies entering the final stages of trials and seeking approval as demand skyrockets.
Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.